Melanotan II has not been approved by the FDA for any cosmetic purpose, and long-term studies on its effects in humans, particularly in fair-skinned populations, remain limited
Advances in GLP-1 investigation: focus on oral semaglutide [PMID: 34526121] Laboratory literature summary: Advances in GLP-1 investigation: focus on oral semaglutide
Daily sun protection is essential for preventing hyperpigmentation and premature aging
UA is considered the major circulating antioxidant and thus provides protection from oxidative stress and consequent damage
GIPR agonism proved essential, buffering the hyperglycemic liability of GcgR activation
PlexusDx compounded semaglutide injections are $189/mo month-to-month, or from $149/mo on the 6-month plan, eliminating the need for insurance pre-authorization and removing the guesswork around out-of-pocket expense